CN116808130A - 一种用于治疗妇科疾病的中药组合物及其制备方法 - Google Patents
一种用于治疗妇科疾病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN116808130A CN116808130A CN202310363831.4A CN202310363831A CN116808130A CN 116808130 A CN116808130 A CN 116808130A CN 202310363831 A CN202310363831 A CN 202310363831A CN 116808130 A CN116808130 A CN 116808130A
- Authority
- CN
- China
- Prior art keywords
- parts
- gynecological diseases
- treating
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 201000010099 disease Diseases 0.000 title claims abstract description 43
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 78
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 28
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 28
- 235000008434 ginseng Nutrition 0.000 claims abstract description 28
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 21
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 14
- 241000258920 Chilopoda Species 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000009136 dragon's blood Substances 0.000 claims abstract description 14
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 13
- 206010004542 Bezoar Diseases 0.000 claims abstract description 12
- 241000239226 Scorpiones Species 0.000 claims abstract description 12
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 241000336291 Cistanche deserticola Species 0.000 claims abstract description 8
- 241000123887 Pulsatilla chinensis Species 0.000 claims abstract description 7
- 241000576429 Forsythia suspensa Species 0.000 claims abstract description 5
- 241000208340 Araliaceae Species 0.000 claims description 27
- 238000001035 drying Methods 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 235000006463 Brassica alba Nutrition 0.000 claims description 9
- 244000140786 Brassica hirta Species 0.000 claims description 9
- 235000011371 Brassica hirta Nutrition 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000009806 pulsatillae Substances 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 7
- 241000220261 Sinapis Species 0.000 claims description 7
- 239000009286 sanguis draxonis Substances 0.000 claims description 7
- 239000009490 scorpio Substances 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 5
- 241000244987 Daiswa polyphylla Species 0.000 claims description 4
- 241000212948 Cnidium Species 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000011802 pulverized particle Substances 0.000 claims 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 abstract description 11
- 206010046914 Vaginal infection Diseases 0.000 abstract description 6
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 39
- 229940079593 drug Drugs 0.000 description 33
- 208000002193 Pain Diseases 0.000 description 31
- 230000036407 pain Effects 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 241000721047 Danaus plexippus Species 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 108090000174 Interleukin-10 Proteins 0.000 description 6
- 108090001005 Interleukin-6 Proteins 0.000 description 6
- 108090001007 Interleukin-8 Proteins 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 241000206469 Pulsatilla Species 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000005787 Cistanche Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 108010002350 Interleukin-2 Proteins 0.000 description 5
- 208000005392 Spasm Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000007803 itching Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 231100000535 infertility Toxicity 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000336315 Cistanche salsa Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000004145 Endometritis Diseases 0.000 description 3
- 241000207201 Gardnerella vaginalis Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 206010008323 cervicitis Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010028470 Mycoplasma infections Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241001631646 Papillomaviridae Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000007893 Salpingitis Diseases 0.000 description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 201000003505 cervical polyp Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000005963 oophoritis Diseases 0.000 description 2
- 208000025661 ovarian cyst Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000005641 Adenomyosis Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000007190 Chlamydia Infections Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000026351 Fallopian Tube disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010036049 Polycystic ovaries Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 101001043830 Rattus norvegicus Interleukin-2 Proteins 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000012085 chronic inflammatory response Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 201000009274 endometriosis of uterus Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- -1 ester compounds Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000002741 leukoplakia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 229920001184 polypeptide Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000031877 prophase Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000019590 thick flavour Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000025421 tumor of uterus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗妇科疾病的中药组合物及其制备方法,所述用于治疗妇科疾病的中药组合物包括以下重量份的组分:金银花13‑17份、人参6‑9份、重楼6‑9份、蛇床子13‑17份、桃仁13‑17份、红花6‑9份、全蝎2‑5份、蜈蚣2‑5份、血竭10‑14份、连翘10‑14份、牛黄6‑9份、黄连2‑5份、白头翁10‑14份、肉苁蓉10‑14份、地肤子10‑14份、麝香2‑4份、冰片2‑5份和白芥子6‑9份。所述中药组合物可用于治疗包括盆腔炎、阴道炎在内的多种妇科疾病。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种用于治疗妇科疾病的中药组合物及其制备方法。
背景技术
常见的妇科疾病主要包括:①阴道炎,外阴瘙痒、麻木、干涩,阴部疼痛(外阴白斑);②宫颈炎,宫颈糜烂,囊肿,宫颈息肉(宫颈癌前期);③子宫内膜炎,腺肌症,囊肿(子宫体小),子宫肌瘤,子宫内膜异位症;④输卵管积水,输卵管炎,输卵管粘连(输卵管不通);⑤附件炎,附件囊肿;⑥卵巢炎,卵巢囊肿,多囊卵巢;⑦月经不调、痛经、腰痛、盆腔炎等引起的不孕不育症;⑧性病:支、衣原体感染,尖锐湿疣,乳头瘤病毒(HPV)。
由于女性生殖器官的特殊性,使得妇科疾病成为女性常见多发病,临床表现也多种多样,病因复杂且多伴有并发症,具有发病率高、易反复、难根治的特点,传统西医注重症状治疗,缺少针对病因的控制,而不同的妇科疾病的病因也不同,例如,《丹溪心法》中提到乳腺炎的病因:乳房阳阴所经,乳头厥阴所属……怒忿所逆,郁闷所遏,厚味所酿,以致厥阴之气不行,故窍不得通,而汗不得出,阴阳之血沸腾,故热甚而化脓。盆腔炎乃源于气血不畅、七情内伤所致机体脉络不同。《傅青主女科》中提到宫颈炎的病因:“夫带下俱是湿症”,带下病总以湿邪为患,病机总以任脉失固、带脉失约概括之,其发病的内因,则是脾、肾功能的失常。而湿有内湿、外湿之分,有学者认,非炎性带下病主要是因为内生之湿,伤及任、带所致,炎性带下病主要为外感热毒之邪,秽浊郁遏化毒生虫,伤及任、带而致。现有大多中药组合物讲求因病施治,只针对单一妇科疾病,而妇科疾病病因多,因此,需要一种安全性的中药组合物,以实现对多种妇科疾病的治疗。
发明内容
针对上述现有技术,本发明的目的是提供一种用于治疗妇科疾病的中药组合物及其制备方法。该中药组合物针对妇科疾病的病因进行合理组方,得到由金银花、人参、重楼、蛇床子、桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子组成的中药组方,上述中药组合物对治疗包括盆腔炎、阴道炎等在内的多种妇科疾病均有效。
为实现上述目的,本发明采用如下技术方案:
本发明的第一方面,提供一种用于治疗妇科疾病的中药组合物,所述用于治疗妇科疾病的中药组合物由如下重量份的原料组成:
金银花13-17份、人参6-9份、重楼6-9份、蛇床子13-17份、桃仁13-17份、红花6-9份、全蝎2-5份、蜈蚣2-5份、血竭10-14份、连翘10-14份、牛黄6-9份、黄连2-5份、白头翁10-14份、肉苁蓉10-14份、地肤子10-14份、麝香2-4份、冰片2-5份和白芥子6-9份。
优选的,金银花15份、人参8份、重楼8份、蛇床子15份、桃仁15份、红花7份、全蝎3份、蜈蚣3份、血竭12份、连翘12份、牛黄7份、黄连3份、白头翁12份、肉苁蓉12份、地肤子12份、麝香3份、冰片4份和白芥子7份。
所述金银花,甘寒清泄,清解疏散,既能清热解毒,又能疏散风热,具有抗菌、抗病毒、解热、抗炎、增强免疫、抗肿瘤、抗过敏等作用。
所述人参,甘补微温,微苦不泄,为补气强身之要药,人参中含有多种人参皂苷、人参多糖、多肽类化合物、酯类化合物、氨基酸、有机酸和生物碱等成分,具有大补元气,复脉固脱、补脾益肺、生津养血和安神益智的功效。
所述重楼,清热解毒,消肿止痛,凉肝定惊,用于治疗疔疮痈肿,咽喉肿痛,蛇虫咬伤,跌扑伤痛,惊风抽搐。
所述蛇床子,含有挥发油,味辛、苦,性温,有散寒祛风、温肾助阳、燥湿、杀虫、止痒之功能效,用于治男子阳萎、阴囊湿痒,女子带下阴痒、子宫寒冷不孕,风湿痹痛、阴道滴虫。
所述桃仁,具有活血祛瘀,润肠通便,止咳平喘的功效,用于经闭痛经,症瘕痞块,肺痈肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。
所述红花,具有活血通经,去瘀止痛的功效,治经闭,症瘕,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。
所述全蝎,具有息风镇痉,通络止痛,攻毒散结的功效,用于肝风内动,痉挛抽搐,小儿惊风,中风口半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
所述蜈蚣,具有息风镇痉,通络止痛,攻毒散结的功效,用于肝风内动,痉挛抽搐,小儿惊风,中风口半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬,蛇虫咬伤。
所述血竭,具有活血定痛,化瘀止血,敛疮生肌的功效,用于跌打损伤,心腹瘀痛,外伤出血,疮疡不敛。
所述连翘,味苦,用于清热,解毒,散结,消肿,治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭,与蛇床子配伍使用,可提高中药组合物的抗炎消肿功效。
所述牛黄,抑制中枢神经系统,具有镇静、镇痛、解热、抗惊厥的作用,具有抗炎、抗病原微生物、抗氧化及抑制肿瘤生长的作用,能助脂肪消化,使胰酵素活化,并可与多种有机物结合成稳定的化合物,而起到解毒作用、
所述黄连,清热燥湿,泻火解毒,用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓,具有抗菌、抗真菌、抗病毒、抗溃疡和抗炎的作用。
所述白头翁,味苦,性寒,归胃、大肠经,具有清热解毒、凉血止痢的功效,可用于治疗热毒血痢、阴痒带下、肛门灼热、温疟寒热、下痢脓血、渴欲饮水、症瘕积聚、舌红苔黄、脉弦数等病症。
所述肉苁蓉,具有抗衰老、调整内分泌、促进代谢及强壮、调节免疫系统等作用,妇女带下、不孕症、四肢不温、月经不调、腰膝酸痛等病症患者适宜食用。
所述地肤子,具有清热利湿,祛风止痒的功效,用于小便涩痛,阴痒带下,风疹,湿疹,皮肤瘙痒。
所述麝香,具有开窍醒神,活血通经,消肿止痛的功效。主治闭证神昏,疮疡肿毒,瘰疬痰核,咽喉肿痛,血瘀经闭,症瘕,心腹暴痛,头痛,跌打损伤,风寒湿痹,难产,死胎,胞衣不下。
所述冰片,具有开窍醒神,清热止痛功效。常用于热病神昏,惊厥,中风痰厥,气郁暴厥,中恶昏迷,胸痹心痛,目赤,口疮,咽喉肿痛,耳道流脓。
所述白芥子,性温,味辛。有温肺豁疾利气、散结通络止痛功效。用于寒疾喘咳、胸胁胀痛、痰滞、经络关节麻木,痰湿流注、阴疽肿毒等症。
金银花、人参、重楼和蛇床子作为君药,具有杀菌消毒、清热补气的功效;桃仁、红花、全蝎、蜈蚣和血竭作为臣药,具有通络止痛、攻毒散结的功效;连翘、牛黄和黄连作为佐药,具有清热解毒、消肿止疼的功效,白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子作为使药,具有清热利湿的功效。
本发明的第二方面,提供一种用于治疗妇科疾病的中药组合物的制备方法,包括以下步骤:
(1)将金银花、人参、重楼和蛇床子混合均匀后,加水煎煮,过滤,得滤液,将滤液加热浓缩,得浸膏;
(2)将桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子干燥后,粉碎过筛,得粉末;
(3)将步骤(2)制得的粉末加入至步骤(1)制得的浸膏中,混合均匀后,干燥,粉碎成细粉,即为用于治疗妇科疾病的中药组合物。
优选的,步骤(1)中,金银花、人参、重楼和蛇床子的总质量与水的质量比为1:(10-12)。
优选的,步骤(1)中,煎煮温度为80-90℃,煎煮时间为12-15h。
优选的,步骤(1)中,加热温度为70-80℃。
优选的,步骤(1)中,所述浸膏的相对密度为1.2-1.3(50℃)
优选的,步骤(2)中,所述干燥温度为50-70℃,粉碎的粒径为50~80目。
优选的,步骤(3)中,干燥温度为80-90℃。
本发明的有益效果:
本发明的用于治疗妇科疾病的中药组合物针对阴道炎、宫颈炎、宫颈糜烂、子宫内膜炎、宫颈息肉(宫颈癌前期)、子宫肿瘤、输卵管炎、卵巢炎、附件炎、卵巢囊肿、月经不调和盆腔炎引起的不孕不育症、支原体和衣原体感染、乳头瘤病毒(HPV)等多种妇科疾病具有显著效果。
本发明中对中草药组方进行合理配伍,具体的,金银花、人参、重楼和蛇床子作为君药,金银花清热解毒,可抗菌、抗病毒;人参清热燥湿、补气养身;重楼消肿止痛、清热解毒;蛇床子解毒止痛、散寒温阴。桃仁、红花、蜈蚣和血竭作为臣药,桃仁和红花活血通经、去瘀止痛,全蝎、蜈蚣和血竭息风镇痉、通络止痛、攻毒散结。连翘、牛黄和黄连作为佐药,连翘清热解毒、消肿止疼,牛黄镇静止痛,黄连清热燥湿、泻火解毒。白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子作为使药,白头翁清热解毒、凉血止痢,肉苁蓉调节内分泌,地肤子清热利湿、祛风止痒,麝香活血通经、消肿止痛,冰片清热止痛,白芥子散结通络止痛。
经过药物君臣分明,相须相使,作为外用药剂,经过血液循环用过十二经络直达病灶发挥作用,具有杀菌、消炎、清热排毒养颜、活血化瘀、通经络、温经止痛、祛瘀生新、温肾暖宫和修复子宫内膜的作用,并且,作为外用药,药力深入,直达患处,可有效治疗妇科疾病,安全无毒副作用,且不易产生抗药性。
具体实施方式
应该指出,以下详细说明都是例示性的,旨在对本申请提供进一步的说明。除非另有指明,本文使用的所有技术和科学术语具有与本申请所属技术领域的普通技术人员通常理解的相同含义。
正如背景技术所述,西医对妇科疾病的治疗偏重于症状,但无法从根本上对病因进行控制。而本发明遵循君臣佐使的配伍原则,选择金银花、人参、重楼和蛇床子作为君药,桃仁、红花、蜈蚣和血竭作为臣药,连翘、牛黄和黄连作为佐药,白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子作为使药。
为了使得本领域技术人员能够更加清楚地了解本申请的技术方案,以下将结合具体的实施例详细说明本申请的技术方案。
本发明实施例中所用的试验材料均为本领域常规的试验材料,均可通过商业渠道购买得到。
实施例1
原料组成:
金银花15份、人参8份、重楼8份、蛇床子15份、桃仁15份、红花7份、全蝎3份、蜈蚣3份、血竭12份、连翘12份、牛黄7份、黄连3份、白头翁12份、肉苁蓉12份、地肤子12份、麝香3份、冰片4份和白芥子7份;
制备方法:
(1)分别将金银花、人参、重楼和蛇床子混合均匀后,加水于85℃下煎煮14h,过滤,得滤液,将滤液加热浓缩至相对密度为1.2(50℃),得浸膏;
所述金银花、人参、重楼和蛇床子的总质量与水的质量比为1:11;
(2)将桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子于60℃下干燥后,粉碎至70目,得粉末;
(3)将步骤(2)制得的粉末加入至步骤(1)制得的浸膏中,混合均匀后,于85℃下干燥,研磨成细粉,即为用于治疗妇科疾病的中药组合物。
实施例2
原料组成:
金银花13份、人参6份、重楼6份、蛇床子13份、桃仁13份、红花6份、全蝎2份、蜈蚣2份、血竭10份、连翘10份、牛黄6份、黄连2份、白头翁10份、肉苁蓉10份、地肤子10份、麝香2份、冰片2份和白芥子6份;
制备方法:
(1)分别将金银花、人参、重楼和蛇床子混合均匀后,加水于80℃下煎煮15h,过滤,得滤液,将滤液加热浓缩至相对密度为1.3(50℃),得浸膏;
所述金银花、人参、重楼和蛇床子的总质量与水的质量比为1:10;
(2)将桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子于50℃下干燥后,粉碎至50目,得粉末;
(3)将步骤(2)制得的粉末加入至步骤(1)制得的浸膏中,混合均匀后,于80℃下干燥,研磨成细粉,即为用于治疗妇科疾病的中药组合物。
实施例3
金银花17份、人参9份、重楼9份、蛇床子17份、桃仁17份、红花9份、全蝎5份、蜈蚣5份、血竭14份、连翘14份、牛黄9份、黄连5份、白头翁14份、肉苁蓉14份、地肤子14份、麝香4份、冰片5份和白芥子9份;
制备方法:
(1)分别将金银花、人参、重楼和蛇床子混合均匀后,加水于90℃下煎煮12h,过滤,得滤液,将滤液加热浓缩至相对密度为1.2(50℃),得浸膏;
所述金银花、人参、重楼和蛇床子的总质量与水的质量比为1:12;
(2)将桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子于70℃下干燥后,粉碎至80目,得粉末;
(3)将步骤(2)制得的粉末加入至步骤(1)制得的浸膏中,混合均匀后,于90℃下干燥,研磨成细粉,即为用于治疗妇科疾病的中药组合物。
对比例1
原料组成:
金银花15份、人参8份、重楼8份、蛇床子15份;
制备方法:
(1)分别将金银花、人参、重楼和蛇床子混合均匀后,加水于85℃下煎煮14h,过滤,得滤液,将滤液加热浓缩至相对密度为1.2(50℃),得浸膏;
所述金银花、人参、重楼和蛇床子的总质量与水的质量比为1:11;
(2)将步骤(1)制得的浸膏于85℃下干燥,研磨成细粉,即得中药组合物。
对比例2
原料组成:
桃仁15份、红花7份、全蝎3份、蜈蚣3份和血竭12份;
制备方法:将桃仁、红花、全蝎、蜈蚣和血竭于60℃下干燥后,粉碎至70目,得粉末,即为中药组合物。
对比例3
原料组成:
连翘12份、牛黄7份和黄连3份;
制备方法:
连翘、牛黄、黄连于60℃下干燥后,粉碎至70目,得粉末,即为中药组合物。
对比例4
原料组成:
白头翁12份、肉苁蓉12份、地肤子12份、麝香3份、冰片4份和白芥子7份;
制备方法:将白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子与60℃下干燥后,粉碎至70目,得粉末,即得用于治疗妇科疾病的中药组合物。
试验例1:体外抑菌试验
参考文献《发酵中草药(本草酵素)的体外抑菌试验评估》(董延江陈稼等)中的实验步骤委托试验机构进行体外抑菌试验。
(1)药液制备
取实施例1和对比例1-4制得的中药组合物各10g,分别加沸水150mL溶解,过滤,经蒸发、抽滤、烘干、浓缩至50mL,使其终浓度为1g/mL,将浓缩后的药液120℃灭菌,备用。
(2)菌种活化
将大肠埃希氏菌、白色念珠菌、白色假丝酵母菌、金黄色葡萄球菌、阴道加德纳菌接种到琼脂斜面培养基上,于37℃下培养24h,用灭菌的生理盐水将菌液稀释,使菌液中的含菌量为105-106CFU/mL,所述菌株均为市售标准株。
(3)体外抑菌试验
采用琼脂平板打孔灌药法进行体外抑菌试验:取大肠埃希氏菌液、白色念珠菌液、白色假丝酵母菌液、金黄色葡萄球菌液、阴道加德纳菌液各200μL,用玻璃棒均匀涂抹于普通琼脂平板上,待菌液被吸收后,在平板上用打孔器打孔,孔间距大于20mm,挖出孔中琼脂,每孔注入步骤(1)制得的药液50μL,37℃培养18h后,分别测量抑菌圈直径大小,重复测量5次取平均值,结果如表1所示,
表1抑菌圈直径/mm
已知:抑菌圈直径≥15mm为高度敏感,10mm≤抑菌圈直径<15mm为较敏感,8mm≤抑菌圈直径<10mm为低敏感,抑菌圈直径<8mm为耐药。
大肠埃希氏菌、金黄色葡萄球菌是盆腔炎和子宫内膜炎的主要致病菌,白色念珠菌、白色假丝酵母菌、阴道加德纳菌是阴道炎的主要致病菌。由表1可以看出,本发明制得的中药组合物对大肠埃希氏菌、白色念珠菌、白色假丝酵母菌、金黄色葡萄球菌和阴道加德纳菌均表现高度敏感,且其对上述六种菌的抑菌圈直径远大于对比例1-4采用单一君药、臣药、佐药和使药的抑菌圈直径,由此可见,本发明采用君药、臣药、佐药和使药进行配伍,共同作用,对盆腔炎、阴道炎等多种妇科疾病有效。
试验例2:动物实验
参考论文《王氏银甲片对慢性盆腔炎大鼠模型的作用机制研究》(宋丹)中的大鼠实验委托实验机构进行动物实验。
(1)动物造模
①混合菌液由金黄色葡萄球菌和大肠埃希菌组成,采用普通肉汤培养基培养37℃,采用麦氏比法计数,取1×109CFU按1:1的比例混合,得混合菌液,并在其对数生长周期时接种使用;
②选取SPF级雌性大鼠进行称重,用10%水合氯醛以0.3mL/100g体重的剂量进行腹腔注射,待大鼠完全麻醉后,在其下腹正中位置作切口,长度0.8-1cm,暴露子宫,用1mL注射针头从子宫分叉处进入大鼠入宫腔,沿着一侧子宫壁向卵巢方向刮两次造成机械损伤,另一侧亦是如此。分别向左右宫腔内注射细菌混合液0.1mL,缝合关腹,造模后15天开始给予药物干预,给药14天,取其血液。
(2)药物干预试验
①分别取实施例1、对比例1-4制得的中药组合物10g加入沸水使其溶解,摇匀并冷却,用0.45μm的滤膜进行过滤,定容至100mL,摇匀制得0.1g/mL的溶液,备用;
②大鼠造模后的第15天,采用每日灌胃的方式进行药物干预,持续两周,每天上午9点进行灌胃,一日两次,灌胃时间分别为早上9点和下午4点,初次灌胃前禁食8-12h,每只大鼠的药物剂量如下所示:
实验组1每天灌胃2.4g实施例1制得中药组合物/100g体重,
实验组2每天灌胃2.4g对比例1制得中药组合物/100g体重,
实验组3每天灌胃2.4g对比例2制得中药组合物/100g体重,
实验组4每天灌胃2.4g对比例3制得中药组合物/100g体重,
实验组5每天灌胃2.4g对比例4制得中药组合物/100g体重;
空白对照组每天灌胃等量生理盐水,
③药物干预14天后,对大鼠禁食12h,取大鼠尾静脉血,采用EILSA法检测IL-2、IL-6、IL-8和IL-10,结果如表1所示。
表2大鼠IL-2、IL-6、IL-8和IL-10
从原理上看,IL-2能与T细胞等表面的相关受体结合,促进T细胞的活化和增殖,同时还能强化NK细胞的活性,增强其杀伤作用,从而促进机体的细胞免疫反应,增强体内的炎症反应;而IL-6能激活NK细胞从而诱导细胞间的黏附分子极化表达,从而介导慢性炎性反应,同时还能促进形成局部的组织粘连以促进肉芽组织的生长;IL-8能够促进大量炎症细胞往炎症部位迁移募集,从而导致炎症细胞出现黏附、聚集以及浸润的现象,从而导致局部组织发生充血、水肿、渗出等各种炎症反应;IL-10是目前所发现的最主要的抑制性细胞因子之一,在机体天然免疫反应的过程中起到负调解的作用,能够限制和最终终止炎症反应。IL-10同时还归于抗原性T辅助细胞2类,其作用主要为下调抗原性T辅助细胞1类(Th1)类细胞的表达,并减弱Th1类细胞因子的作用。
由表2可以看出,本发明制得的中药组合物可有效抑制慢性盆腔炎大鼠模型中血清IL-2、IL-6和IL-8,抑制IL-2从而抑制体内炎症反应,抑制IL-6从而减少局部组织黏连和肉芽组织的生产,抑制IL-8从而缓解组织充血、水肿,同时,有效促进IL-10的释放。而采用对比例1-4制得的中药组合物进行灌胃后,虽然也会抑制IL-2、IL-8和IL-6,促进IL-10,但其对促炎因子的抑制和促进作用远小于实施例1制得的中药组合物,由此可见,本发明采用君药、臣药、佐药和使药进行配伍,共同作用,发挥杀菌消炎、活血化瘀、理气止痛的功效。
以上所述仅为本申请的优选实施例而已,并不用于限制本申请,对于本领域的技术人员来说,本申请可以有各种更改和变化。凡在本申请的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本申请的保护范围之内。
Claims (8)
1.一种用于治疗妇科疾病的中药组合物,其特征在于,所述用于治疗妇科疾病的中药组合物包括如下重量份的组分:金银花13-17份、人参6-9份、重楼6-9份、蛇床子13-17份、桃仁13-17份、红花6-9份、全蝎2-5份、蜈蚣2-5份、血竭10-14份、连翘10-14份、牛黄6-9份、黄连2-5份、白头翁10-14份、肉苁蓉10-14份、地肤子10-14份、麝香2-4份、冰片2-5份和白芥子6-9份。
2.如权利要求1所述的用于治疗妇科疾病的中药组合物,其特征在于,所述用于治疗妇科疾病的中药组合物包括如下重量份的组分:金银花15份、人参8份、重楼8份、蛇床子15份、桃仁15份、红花7份、全蝎3份、蜈蚣3份、血竭12份、连翘12份、牛黄7份、黄连3份、白头翁12份、肉苁蓉12份、地肤子12份、麝香3份、冰片4份和白芥子7份。
3.权利要求1或2所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)将金银花、人参、重楼和蛇床子混合均匀后,加水煎煮,过滤,得滤液,将滤液加热浓缩,得浸膏;
(2)将桃仁、红花、全蝎、蜈蚣、血竭、连翘、牛黄、黄连、白头翁、肉苁蓉、地肤子、麝香、冰片和白芥子干燥后,粉碎过筛,得粉末;
(3)将步骤(2)制得的粉末加入至步骤(1)制得的浸膏中,混合均匀后,干燥,研磨成细粉,即为用于治疗妇科疾病的中药组合物。
4.如权利要求3所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,步骤(1)中,金银花、人参、重楼和蛇床子的总质量与水的质量比为1:(10-12)。
5.如权利要求3所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,步骤(1)中,煎煮温度为80-90℃,煎煮时间为12-15h。
6.如权利要求3所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,步骤(1)中,所述浸膏的相对密度为1.2-1.3(50℃)。
7.如权利要求3所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,步骤(2)中,干燥温度为50-70℃,粉碎的粒径为50-80目。
8.如权利要求3所述的用于治疗妇科疾病的中药组合物的制备方法,其特征在于,步骤(3)中,干燥温度为80-90℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310363831.4A CN116808130A (zh) | 2023-04-07 | 2023-04-07 | 一种用于治疗妇科疾病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310363831.4A CN116808130A (zh) | 2023-04-07 | 2023-04-07 | 一种用于治疗妇科疾病的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116808130A true CN116808130A (zh) | 2023-09-29 |
Family
ID=88117404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310363831.4A Pending CN116808130A (zh) | 2023-04-07 | 2023-04-07 | 一种用于治疗妇科疾病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116808130A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393873A (zh) * | 2013-08-15 | 2013-11-20 | 梁国才 | 一种治疗痔疮的外用药剂 |
CN104435376A (zh) * | 2013-09-13 | 2015-03-25 | 李广臣 | 新正宫丸 |
CN105902787A (zh) * | 2016-05-19 | 2016-08-31 | 李广臣 | 用于治疗妇科病的外用药 |
CN106310095A (zh) * | 2016-09-14 | 2017-01-11 | 李广臣 | 一种用于治疗妇科病的内服药 |
-
2023
- 2023-04-07 CN CN202310363831.4A patent/CN116808130A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393873A (zh) * | 2013-08-15 | 2013-11-20 | 梁国才 | 一种治疗痔疮的外用药剂 |
CN104435376A (zh) * | 2013-09-13 | 2015-03-25 | 李广臣 | 新正宫丸 |
CN105902787A (zh) * | 2016-05-19 | 2016-08-31 | 李广臣 | 用于治疗妇科病的外用药 |
CN106310095A (zh) * | 2016-09-14 | 2017-01-11 | 李广臣 | 一种用于治疗妇科病的内服药 |
Non-Patent Citations (2)
Title |
---|
吴秀青;: "中药治疗乳腺增生93例临床效果观察", 临床合理用药杂志, vol. 6, no. 7, 10 July 2013 (2013-07-10), pages 98 - 99 * |
李俊箐;: "李祥云教授巧用虫类药治疗妇科病经验", 中医药导报, vol. 21, no. 18, 30 September 2015 (2015-09-30), pages 96 - 98 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101288710B (zh) | 一种治疗妇科炎症的药物 | |
CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
CN103393821A (zh) | 一种治疗慢性盆腔炎的中药组合物及其制备方法 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN103070963A (zh) | 一种治疗感染白色念珠菌疾病的中药制剂 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN107412468A (zh) | 一种治疗生殖系统感染性疾病的中药组合物、碳基贴、碳基贴的制备方法及碳基贴的应用 | |
CN103536826A (zh) | 一种治疗阴道炎的中药组合物及其制备方法 | |
CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
CN103751532A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN104147559A (zh) | 一种治疗妇科子宫内膜炎的中药制剂 | |
CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN103223132B (zh) | 一种治疗过敏性皮炎的药物及制备方法 | |
CN105362839A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN102058732B (zh) | 治疗急性盆腔炎的中药 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN116808130A (zh) | 一种用于治疗妇科疾病的中药组合物及其制备方法 | |
CN103623286B (zh) | 一种治疗生殖器疱疹的中草药 | |
CN103735950B (zh) | 一种用于防治痔疮的中药组合物及其制备方法 | |
CN105147850A (zh) | 用于治疗小儿过敏性紫癜的中药组合物 | |
CN105412596A (zh) | 一种治疗肝肿瘤的中药组合物及其制备方法 | |
CN104587202A (zh) | 一种治疗湿疹的中药膏剂及其制备方法 | |
CN104887906A (zh) | 一种治疗母犬子宫蓄脓的中药片剂及其制备方法 | |
CN104127774A (zh) | 一种用于治疗皮肤癣的药剂及其制备方法 | |
CN114984168B (zh) | 一种中药组合物、桃红疏通合剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |